Published on in Vol 5, No 4 (2016): Oct-Dec

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease

ENHANCE—(Electronic Hydroxyurea Adherence): A Protocol to Increase Hydroxyurea Adherence in Patients with Sickle Cell Disease

Journals

  1. Yahouédéhou S, da Guarda C, Figueiredo C, Santiago R, Carvalho S, Fiuza L, Ndidi U, Oliveira R, Carvalho M, Nascimento V, Rocha L, Lyra I, Adorno E, Goncalves M, Arez A. Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia. PLOS ONE 2019;14(7):e0218040 View
  2. Reeves S, Jary H, Gondhi J, Raphael J, Lisabeth L, Dombkowski K. Hydroxyurea Initiation Among Children With Sickle Cell Anemia. Clinical Pediatrics 2019;58(13):1394 View
  3. Creary S, Chisolm D, Stanek J, Hankins J, O'Brien S. A Multidimensional Electronic Hydroxyurea Adherence Intervention for Children With Sickle Cell Disease: Single-Arm Before-After Study. JMIR mHealth and uHealth 2019;7(8):e13452 View
  4. Badawy S, Cronin R, Hankins J, Crosby L, DeBaun M, Thompson A, Shah N. Patient-Centered eHealth Interventions for Children, Adolescents, and Adults With Sickle Cell Disease: Systematic Review. Journal of Medical Internet Research 2018;20(7):e10940 View
  5. Ozdogu H, Boga C, Asma S, Kozanoglu I, Gereklioglu C, Yeral M, Buyukkurt N, Solmaz S, Korur A, Aytan P, Maytalman E, Kasar M. Organ damage mitigation with the Baskent Sickle Cell Medical Care Development Program (BASCARE). Medicine 2018;97(6):e9844 View
  6. Ingerski L, Loew M, Porter J, Su Y, Zhang H, Hankins J, Wang W. Use of Wise Device Technology to Measure Adherence to Hydroxyurea Therapy in Youth With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology 2021;43(1):e19 View